Wells Fargo’s Pfizer PFE Stock Holding History

Wells Fargo’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.41M	Buy	+100,000	New	+$2.62M	﹤0.01%	3432
2025 Q2	–	Sell	-300,000	Closed	-$7.6M	–	7315
2025 Q1	$7.6M	Sell	300,000 -85,000	-22%	-$2.22M	﹤0.01%	2088
2024 Q4	$10.2M	Buy	385,000 +95,800	+33%	+$2.6M	﹤0.01%	1871
2024 Q3	$8.37M	Buy	+289,200	New	+$8.44M	﹤0.01%	1975
2024 Q1	–	Sell	-4,300	Closed	-$124K	–	7662
2023 Q4	$124K	Hold	4,300	–	–	﹤0.01%	4772
2023 Q3	$143K	Hold	4,300	–	–	﹤0.01%	4560
2023 Q2	$158K	Sell	4,300 -20,100	-82%	-$782K	﹤0.01%	4730
2023 Q1	$996K	Buy	24,400 +20,100	+467%	+$868K	﹤0.01%	3382
2022 Q4	$220K	Buy	+4,300	New	+$206K	﹤0.01%	4121
2022 Q2	–	Sell	-400,000	Closed	-$20.7M	–	7309
2022 Q1	$20.7M	Sell	400,000 -83,200	-17%	-$4.32M	0.01%	1283
2021 Q4	$28.5M	Buy	+483,200	New	+$23.9M	0.01%	1096
2021 Q2	–	Sell	-20,000	Closed	-$725K	–	7297
2021 Q1	$725K	Sell	20,000 -173,300	-90%	-$6.15M	﹤0.01%	4464
2020 Q4	$104K	Sell	193,300 -166,957	-46%	-$6.12M	﹤0.01%	5341
2020 Q3	$243K	Buy	360,257 +106,875	+42%	+$3.75M	﹤0.01%	4853
2020 Q2	$17K	Buy	+253,382	New	+$8.61M	﹤0.01%	5737
2017 Q1	–	Sell	-210,800	Closed	-$515K	–	6448
2016 Q4	$515K	Hold	210,800	–	–	﹤0.01%	4184
2016 Q3	$819K	Sell	210,800 -176,545	-46%	-$5.9M	﹤0.01%	3621
2016 Q2	$1.76M	Sell	387,345 -614,377	-61%	-$19.6M	﹤0.01%	3061
2016 Q1	$211K	Buy	+1,001,722	New	+$28.6M	﹤0.01%	4383
2015 Q1	–	Sell	-210,800	Closed	-$69K	–	6302
2014 Q4	$69K	Buy	+210,800	New	+$6.04M	﹤0.01%	4894
2014 Q2	–	Sell	-260,338	Closed	-$75K	–	6241
2014 Q1	$75K	Buy	+260,338	New	+$7.76M	﹤0.01%	4780

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Wells Fargo's PFE Position: Q2 2026 in Review

Wells Fargo increased its Pfizer (PFE) stake by 3.4% in Q2 2026, buying an estimated $17.3M and bringing the position to 20,193,675 shares worth $486M. The position accounts for 0.08% of the portfolio, ranked #220.

Wells Fargo first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.76B in Q3 2018. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Wells Fargo held 20,193,675 shares of Pfizer worth $486M as of Q2 2026.
Wells Fargo bought 660,366 Pfizer shares in Q2 2026, an estimated $17.3M.
Pfizer made up 0.08% of Wells Fargo's portfolio in Q2 2026, its #220 holding.
Wells Fargo first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
Wells Fargo's Pfizer position peaked at $1.76B in Q3 2018.
2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.